1.
Vestn Oftalmol
; 107(6): 8-11, 1991.
Article
in Russian
| MEDLINE
| ID: mdl-1781135
ABSTRACT
Clinical trials of the hypotensive effect of 0.5% betoptic, an antiglaucoma drug manufactured by Alcon (USA), were carried out at three ophthalmologic hospitals. Similar results obtained in all the trials permit a conclusion on a high hypotensive efficacy of this drug in patients with primary open-angle glaucoma. The drug was well tolerated by the patients.
Subject(s)
Betaxolol/therapeutic use , Glaucoma/drug therapy , Aged , Betaxolol/administration & dosage , Betaxolol/pharmacology , Drug Tolerance , Glaucoma, Angle-Closure/drug therapy , Glaucoma, Open-Angle/drug therapy , Humans , Intraocular Pressure/drug effects , Middle Aged , Time Factors
2.
Vestn Oftalmol
; (3): 20-2, 1978.
Article
in Russian
| MEDLINE
| ID: mdl-28604